𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ca 50 as tumoral marker in pancreatic cancer

✍ Scribed by C. Pasquali; C. Sperti; A. Alfano D'Andrea; B. Bonadimani; M. Rambotti; S. Pedrazzoli

Book ID
116006547
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
128 KB
Volume
28
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum ca 50 as a tumor marker in pancrea
Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9
✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different

Immunology, tumor markers, and pancreati
Immunology, tumor markers, and pancreatic cancer
✍ Norman Zamcheck πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 765 KB

## CARCINOEMBRYONIC ANTIGEN Recently, studies have been made of the use and limitations of CEA in diagnosis, detection, and treatment monitoring of patients with pancreatic cancer and related diseases, including acute and chronic pancreatitis. in cancer of the pancreas (1). Subsequently, in an att

CA 494β€”a new tumor marker for the diagno
CA 494β€”a new tumor marker for the diagnosis of pancreatic cancer
✍ Helmut Friess; Markus BΓΌchler; Bernhard Auerbach; Alexander Weber; Peter Malfert πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 569 KB

## Abstract In 59 patients with ductal pancreatic cancer the monoclonal antibody (MAb) BW 494, which detects the CA 494 glycoprotein antigen, was analyzed in comparison with the reference tumor markers CA 19‐9 and CEA. Eighty‐one patients with non‐pancreatic malignancies of the gastraintestinal (GI